Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 24-Sep-24 4:40 PM View:  | Versant Venture Capital Vi,... 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 20-Sep-24 | Sale | 1,132,570 | $6.53 | $7,395,200.00 | (14%) 8.33M to 7.2M | |
| 13-Sep-24 6:44 PM View: | Versant Venture Capital Vi,... 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 13-Sep-24 | Sale | 9,269 | $6.16 | $57,099.80 | (< 1%) 8.34M to 8.33M | |
| 13-Sep-24 6:44 PM View: | Versant Venture Capital Vi,... 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 12-Sep-24 | Sale | 16,047 | $6.00 | $96,309.30 | (< 1%) 8.36M to 8.34M | |
| 13-Sep-24 6:44 PM View: | Versant Venture Capital Vi,... 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 11-Sep-24 | Sale | 541,897 | $6.00 | $3,251,380.00 | (6%) 8.9M to 8.36M | |
| 09-Jul-24 4:15 PM View: | Dunn Edmund Principal Accounting Officer | Monte Rosa Therapeutics, Inc. (GLUE) | 05-Jul-24 | Sale | 1,610 | $3.83 | $6,166.46 | (10%) 15.55K to 13.94K | |
| 05-Jun-24 4:10 PM View: | Dunn Edmund Principal Accounting Officer | Monte Rosa Therapeutics, Inc. (GLUE) | 03-Jun-24 | Sale | 1,207 | $4.04 | $4,875.80 | (7%) 16.76K to 15.55K | |
| 30-Jun-21 6:04 PM View: | Landsman Liza 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 1,050,000 | $19.00 | $19,950,000.00 | 16% 6.64M to 7.69M | |
| 30-Jun-21 6:06 PM View: | Makower Joshua 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion Duplicate | 6,642,300 | -- | -- | 100% 0 to 6.64M | |
| 30-Jun-21 6:06 PM View: | Mathers Edward T 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 1,050,000 | $19.00 | $19,950,000.00 | 16% 6.64M to 7.69M | |
| 30-Jun-21 6:08 PM View: | Sonsini Peter W. 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion Duplicate | 6,642,300 | -- | -- | 100% 0 to 6.64M | |
| 30-Jun-21 5:00 PM View: | Versant Venture Capital Vi,... 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion | 6,515,870 | -- | -- | 2300% 283.25K to 6.8M | |
| 30-Jun-21 6:08 PM View: | Walker Paul Edward 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 1,050,000 | $19.00 | $19,950,000.00 | 16% 6.64M to 7.69M | |
| 30-Jun-21 4:08 PM View: | Cormorant Asset Management,... | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion | 2,602,200 | -- | -- | 100% 2.6M to 5.2M | |
| 30-Jun-21 5:59 PM View: | New Enterprise Associates 1... 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion | 6,642,300 | -- | -- | 100% 0 to 6.64M | |
| 30-Jun-21 6:00 PM View: | Baskett Forest 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 1,050,000 | $19.00 | $19,950,000.00 | 16% 6.64M to 7.69M | |
| 30-Jun-21 6:02 PM View: | Chang Carmen 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion Duplicate | 6,642,300 | -- | -- | 100% 0 to 6.64M | |
| 30-Jun-21 6:02 PM View: | Florence Anthony A. Jr. 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 1,050,000 | $19.00 | $19,950,000.00 | 16% 6.64M to 7.69M | |
| 30-Jun-21 6:05 PM View: | Makhzoumi Mohamad 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion Duplicate | 6,642,300 | -- | -- | 100% 0 to 6.64M | |
| 30-Jun-21 6:06 PM View: | Makower Joshua 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 1,050,000 | $19.00 | $19,950,000.00 | 16% 6.64M to 7.69M | |
| 30-Jun-21 6:07 PM View: | Sandell Scott D 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion Duplicate | 6,642,300 | -- | -- | 100% 0 to 6.64M | |
| 30-Jun-21 6:08 PM View: | Sonsini Peter W. 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 1,050,000 | $19.00 | $19,950,000.00 | 16% 6.64M to 7.69M | |
| 30-Jun-21 5:00 PM View: | Versant Venture Capital Vi,... 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion | 1,940,040 | -- | -- | 29% 6.8M to 8.74M | |
| 30-Jun-21 6:09 PM View: | Yang Rick 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion Duplicate | 6,642,300 | -- | -- | 100% 0 to 6.64M | |
| 30-Jun-21 4:08 PM View: | Cormorant Asset Management,... | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase | 600,000 | $19.00 | $11,400,000.00 | 12% 5.2M to 5.8M | |
| 30-Jun-21 5:05 PM View: | Bolzon Bradley J Phd Director 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion | 8,455,910 | -- | -- | 2985% 283.25K to 8.74M | |
| 30-Jun-21 5:59 PM View: | New Enterprise Associates 1... 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase | 1,050,000 | $19.00 | $19,950,000.00 | 16% 6.64M to 7.69M | |
| 30-Jun-21 6:01 PM View: | Behbahani Ali Director 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion Duplicate | 6,642,300 | -- | -- | 100% 0 to 6.64M | |
| 30-Jun-21 6:02 PM View: | Chang Carmen 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 1,050,000 | $19.00 | $19,950,000.00 | 16% 6.64M to 7.69M | |
| 30-Jun-21 6:04 PM View: | Landsman Liza 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion Duplicate | 6,642,300 | -- | -- | 100% 0 to 6.64M | |
| 30-Jun-21 6:05 PM View: | Makhzoumi Mohamad 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 1,050,000 | $19.00 | $19,950,000.00 | 16% 6.64M to 7.69M | |
| 30-Jun-21 6:06 PM View: | Mathers Edward T 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion Duplicate | 6,642,300 | -- | -- | 100% 0 to 6.64M | |
| 30-Jun-21 6:07 PM View: | Sandell Scott D 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 1,050,000 | $19.00 | $19,950,000.00 | 16% 6.64M to 7.69M | |
| 30-Jun-21 6:08 PM View: | Walker Paul Edward 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion Duplicate | 6,642,300 | -- | -- | 100% 0 to 6.64M | |
| 30-Jun-21 5:00 PM View: | Versant Venture Capital Vi,... 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase | 157,895 | $19.00 | $3,000,000.00 | 2% 8.74M to 8.9M | |
| 30-Jun-21 6:09 PM View: | Yang Rick 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 1,050,000 | $19.00 | $19,950,000.00 | 16% 6.64M to 7.69M | |
| 30-Jun-21 5:05 PM View: | Bolzon Bradley J Phd Director 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 157,895 | $19.00 | $3,000,000.00 | 2% 8.74M to 8.9M | |
| 30-Jun-21 6:00 PM View: | Baskett Forest 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion Duplicate | 6,642,300 | -- | -- | 100% 0 to 6.64M | |
| 30-Jun-21 6:01 PM View: | Behbahani Ali Director 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 1,050,000 | $19.00 | $19,950,000.00 | 16% 6.64M to 7.69M | |
| 30-Jun-21 6:02 PM View: | Florence Anthony A. Jr. 10% Owner | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion Duplicate | 6,642,300 | -- | -- | 100% 0 to 6.64M |
